<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01379651</url>
  </required_header>
  <id_info>
    <org_study_id>FBFBN</org_study_id>
    <nct_id>NCT01379651</nct_id>
  </id_info>
  <brief_title>Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy</brief_title>
  <acronym>EGGSOTI</acronym>
  <official_title>Specific Oral Tolerance Induction in Children With Severe Egg Allergy: A Randomized Controlled Trial Using a 6 Months Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Buon Consiglio Fatebenefratelli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Buon Consiglio Fatebenefratelli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of a 6-month specific oral tolerance induction (SOTI) protocol in
      inducing tolerance (maximal dose of raw egg emulsion tolerated) in children with severe
      IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental
      exposure to egg.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oral immunotherapy consisted in the administration of increasing amounts of raw emulsion egg.
      The children started with 1 drop of undiluted raw egg emulsion (0.05 ml) flavored with
      vanilla and cacao, hidden by the parents in the child's breakfast (cow's milk, soymilk, fruit
      juice or other). The dose was doubled at intervals of about one month in the day hospital.
      The increases in dose were customized for each subject based on the frequency and severity of
      side effects, or when an inter-current illness or asthma worsening intervened during the
      SOTI.

      The investigators limited the SOTI protocol to six months for all patients, irrespective of
      the dose reached, in order to favor the adherence of families to the study.

      When objective symptoms seemed more important (grade 2, 3 and 4 reaction), medical treatment
      was given. Subjects were discontinued from the study in case of severe adverse reactions
      (grade 5 reaction). Parents were advised they could telephone investigators 24 hours a day
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Children That Achieved Total (40 ml) or Partial (Less Than 40 ml But at Least 10 ml) Tolerance to Raw Egg</measure>
    <time_frame>baseline and 6 months</time_frame>
    <description>To evaluate the efficacy of a 6-month Specific Oral Tolerance Induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated after 6 months) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Before and after SOTI, we evaluated the change in the median weal diameter in millimeters, using egg white SPTs, end-point SPT and PP.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>- Egg Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Specific oral tolerance induction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>controls were kept on an egg-free diet for 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specific oral tolerance induction</intervention_name>
    <description>Specific oral tolerance induction consisted in the administration of increasing amounts of raw emulsion egg</description>
    <arm_group_label>Specific oral tolerance induction</arm_group_label>
    <other_name>SOTI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 1 anaphylactic reaction (grade 3, 4 and 5 according to Sampson's grading
             after accidental exposure to trace amounts of egg or egg-derivative products,
             requiring emergency treatment, at least 1 year before enrollment

          -  demonstration of egg white specific IgE by the skin prick test (SPT), end-point SPT,
             raw egg white prick-by-prick (PP) and egg white-specific IgE determination

          -  positive double-blind placebo-controlled food challenge (DBPCFC) at a dose of less
             than 0.9 ml of raw emulsion egg

        Exclusion Criteria:

          -  age below 5 years

          -  poorly controlled asthma

          -  parents with a history of unreliable management of complications and treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iride Dello Iacono, pediatrician</last_name>
    <role>Study Director</role>
    <affiliation>Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unit of Pediatrics, Fatebenefratelli Hospital</name>
      <address>
        <city>Benevento</city>
        <zip>82100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Calvani M, Giorgio V, Miceli Sopo S. Specific oral tolerance induction for food. A systematic review. Eur Ann Allergy Clin Immunol. 2010 Feb;42(1):11-9. Review.</citation>
    <PMID>20355360</PMID>
  </reference>
  <reference>
    <citation>Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003 Jun;111(6 Pt 3):1601-8. Review.</citation>
    <PMID>12777599</PMID>
  </reference>
  <reference>
    <citation>Sicherer SH, Sampson HA. 9. Food allergy. J Allergy Clin Immunol. 2006 Feb;117(2 Suppl Mini-Primer):S470-5. Review.</citation>
    <PMID>16455349</PMID>
  </reference>
  <reference>
    <citation>Barbi E, Berti I, Longo G. Food allergy: from the of loss of tolerance induced by exclusion diets to specific oral tolerance induction. Recent Pat Inflamm Allergy Drug Discov. 2008 Nov;2(3):212-4. Review.</citation>
    <PMID>19076011</PMID>
  </reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2011</study_first_submitted>
  <study_first_submitted_qc>June 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2011</study_first_posted>
  <results_first_submitted>June 24, 2011</results_first_submitted>
  <results_first_submitted_qc>August 1, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 30, 2011</results_first_posted>
  <last_update_submitted>September 19, 2011</last_update_submitted>
  <last_update_submitted_qc>September 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Buon Consiglio Fatebenefratelli</investigator_affiliation>
    <investigator_full_name>Iride Dello Iacono</investigator_full_name>
    <investigator_title>pediatrician</investigator_title>
  </responsible_party>
  <keyword>Egg allergy,specific oral tolerance induction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Egg Hypersensitivity</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>26 children (14 boys, 12 girls; median age: 7 years 7 months; range 5-11 years), with severe IgE-mediated egg allergy (EA) were recruited from the Pediatric and Allergology Unit of the Fatebenefratelli Hospital in Benevento, Italy, from January 2008 to December 2009.</recruitment_details>
      <pre_assignment_details>6 children(4 males and 2 females)were excluded from the study: one child because the parents had a history of unreliable management of complications and treatments;2 children because of poorly controlled asthma;3 children because of a positive double-blind placebo-controlled food challenge (DBPCFC) at a dose of raw egg emulsion higher than 0.9 ml.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Specific Oral Tolerance Induction</title>
          <description>Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>controls were kept on an egg-free diet for 6 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Specific Oral Tolerance Induction</title>
          <description>Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>controls were kept on an egg-free diet for 6 months</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.033" spread="1.768"/>
                    <measurement group_id="B2" value="7.676" spread="3.203"/>
                    <measurement group_id="B3" value="7.354" spread="2.607"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Children That Achieved Total (40 ml) or Partial (Less Than 40 ml But at Least 10 ml) Tolerance to Raw Egg</title>
        <description>To evaluate the efficacy of a 6-month Specific Oral Tolerance Induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated after 6 months) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.</description>
        <time_frame>baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Specific Oral Tolerance Induction</title>
            <description>Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>controls were kept on an egg-free diet for 6 months</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Children That Achieved Total (40 ml) or Partial (Less Than 40 ml But at Least 10 ml) Tolerance to Raw Egg</title>
          <description>To evaluate the efficacy of a 6-month Specific Oral Tolerance Induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated after 6 months) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP</title>
        <description>Before and after SOTI, we evaluated the change in the median weal diameter in millimeters, using egg white SPTs, end-point SPT and PP.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>We were unable to calculate sample size because no quantitative data about the clinical outcome could be hypothesized. Indeed, the few reports of food causing allergy, the protocol, the way of SOTI administration and food doses administered yielded reported variable results. the analysis was per intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Specific Oral Tolerance Induction</title>
            <description>Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>controls were kept on an egg-free diet for 6 months</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP</title>
          <description>Before and after SOTI, we evaluated the change in the median weal diameter in millimeters, using egg white SPTs, end-point SPT and PP.</description>
          <population>We were unable to calculate sample size because no quantitative data about the clinical outcome could be hypothesized. Indeed, the few reports of food causing allergy, the protocol, the way of SOTI administration and food doses administered yielded reported variable results. the analysis was per intention to treat</population>
          <units>mm diameter</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="4" upper_limit="13"/>
                    <measurement group_id="O2" value="10" lower_limit="5.5" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Specific Oral Tolerance Induction</title>
          <description>Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>controls were kept on an egg-free diet for 6 months</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>allergic reaction</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <counts group_id="E1" events="53" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Iride Dello Iacono</name_or_title>
      <organization>Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy</organization>
      <phone>+39 824 771111</phone>
      <email>iridedello@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

